Prestige Consumer Healthcare Inc(PBH) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. It also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray, and Hydralyte for oral rehydration products. The company sells through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Current Price

$44.34

RSI

52.649

Beta:

0.693325

February 04, 2021
1.6B
43.5M

1.314 %
-9.917 %
6.176 %
16.497 %

$770,367,000
$764,963,000
$930,443,000
$786,521,000
$702,990,000
$714,623,000
0.706 %
-21.632 %
18.299 %
11.882 %
-1.655 %

$191,151,000
$-38,055,000
$107,086,000
$110,850,000
$157,185,000
$127,458,000
119.908 %
-381.398 %
-3.515 %
-41.800 %
23.323 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.